3M announces filing of Form 10 for planned spinoff of health care business

3M announced the filing of a Form 10 registration statement with the U.S. SEC for the planned spin-off of its Health Care business as the newly independent health care company Solventum. Solventum is anticipated to spin off from 3M on April 1, 2024, subject to final approval from the 3M Board of Directors and other required conditions. Solventum has applied to list on the New York Stock Exchange as “SOLV”. Solventum had sales of $8.2B in 2023, and will include more than 20,000 employees led by Bryan Hanson as CEO, Wayde McMillan as CFO, and Carrie Cox as Board Chair.